Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-16

FDA Approved: ERIBULIN MESYLATE — Original Application (XGen Pharmaceuticals DJB, Inc.)

View source ↗

Summary

FDA approved the Original Application for ERIBULIN MESYLATE (generic) by XGen Pharmaceuticals DJB, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

ORIG AP for ERIBULIN MESYLATE (ERIBULIN MESYLATE)